✦ LIBER ✦

Alemtuzumab induces enhanced apoptosis in vitro in B-cells from patients with chronic lymphocytic leukemia by antibody-dependent cellular cytotoxicity

✍ Scribed by Holger Nückel; Ulrich H. Frey; Alexander Röth; Ulrich Dührsen; Winfried Siffert

Book ID: 113585384
Publisher: Elsevier Science
Year: 2005
Tongue: English
Weight: 200 KB
Volume: 514
Category: Article
ISSN: 0014-2999
DOI: 10.1016/j.ejphar.2005.03.024

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Evaluation of apoptosis induced in vitro

Evaluation of apoptosis induced in vitro by cladribine (2-CdA) combined with anthracyclines in lymphocytes from patients with B-cell chronic lymphocytic leukemia

✍ A. Szmigielska-Kaplon; P. Smolewski; M. Najder; T. Robak 📂 Article 📅 2002 🏛 Springer 🌐 English ⚖ 196 KB

Direct and complement dependent cytotoxi

Direct and complement dependent cytotoxicity in CLL cells from patients with high-risk early–intermediate stage chronic lymphocytic leukemia (CLL) treated with alemtuzumab and rituximab

✍ Clive S. Zent; Charla R. Secreto; Betsy R. LaPlant; Nancy D. Bone; Timothy G. Ca 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 373 KB

The mechanism of cytotoxicity of alemtuzumab and rituximab in chronic lymphocytic leukemia (CLL) is not well understood. We obtained fresh CLL cells from early-intermediate stage high-risk patients just prior to treatment with alemtuzumab and rituximab to study mechanisms of action and resistance. A